Researcher.Life Logo

BMC Immunology : Impact Factor & More

eISSN: 1471-2172pISSN: 1471-2172
JournalOpen Access

Key Metrics

CiteScore
4.5
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Immunology
SNIP
0.92
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on BMC Immunology

BMC Immunology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2390 | USD 2790 | GBP 1990
Publication Time21
Editorial Review ProcessOpen peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 21
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessOpen peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in BMC Immunology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BMC Immunology

Upregulation of miR-223 by SIRT1 attenuates the inflammatory response in neonatal sepsis.
  • 9 Jan 2026
  • BMC immunology
Retrospective, single-center analysis of autoimmune hepatitis in Yemeni adults: clinical features, treatment, and outcomes.
  • 7 Jan 2026
  • BMC immunology
Lactate dehydrogenase to albumin ratio as a convenient parameter for predicting the severity of Behçet disease: a cross-sectional study.
  • 7 Jan 2026
  • BMC immunology
TZ1391: a computationally designed circular mRNA multi-epitope vaccine candidate against Mycobacterium tuberculosis via TLR3 immunomodulation.
  • 2 Jan 2026
  • BMC immunology
Investigating monoclonal antibody against cytokeratin 19 tumor marker.
  • 28 Dec 2025
  • BMC immunology
The relationship between the biological biomarker lnc-DC and female patients with Sjögren's disease.
  • 26 Dec 2025
  • BMC immunology
Upregulation of miR-223 by SIRT1 attenuates the inflammatory response in neonatal sepsis.
  • 9 Jan 2026
  • BMC immunology
Retrospective, single-center analysis of autoimmune hepatitis in Yemeni adults: clinical features, treatment, and outcomes.
  • 7 Jan 2026
  • BMC immunology
Lactate dehydrogenase to albumin ratio as a convenient parameter for predicting the severity of Behçet disease: a cross-sectional study.
  • 7 Jan 2026
  • BMC immunology
TZ1391: a computationally designed circular mRNA multi-epitope vaccine candidate against Mycobacterium tuberculosis via TLR3 immunomodulation.
  • 2 Jan 2026
  • BMC immunology
Investigating monoclonal antibody against cytokeratin 19 tumor marker.
  • 28 Dec 2025
  • BMC immunology
The relationship between the biological biomarker lnc-DC and female patients with Sjögren's disease.
  • 26 Dec 2025
  • BMC immunology

FAQs on BMC Immunology